These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33916924)

  • 1. Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses.
    Jang YH; Seong BL
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33916924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation live-attenuated influenza vaccine platforms.
    Ullah S; Ross TM
    Expert Rev Vaccines; 2022 Aug; 21(8):1097-1110. PubMed ID: 35502639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Call for a paradigm shift in the design of universal influenza vaccines by harnessing multiple correlates of protection.
    Jang YH; Seong BL
    Expert Opin Drug Discov; 2020 Dec; 15(12):1441-1455. PubMed ID: 32783765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Quest for a Truly Universal Influenza Vaccine.
    Jang YH; Seong BL
    Front Cell Infect Microbiol; 2019; 9():344. PubMed ID: 31649895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-Influenza A Protection by Prime-Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model.
    Jang YH; Kim JY; Byun YH; Son A; Lee JY; Lee YJ; Chang J; Seong BL
    Front Immunol; 2018; 9():116. PubMed ID: 29449842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an Alternative Modified Live Influenza B Virus Vaccine.
    Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
    Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
    Front Immunol; 2019; 10():756. PubMed ID: 31105689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge.
    Isakova-Sivak I; Matyushenko V; Kotomina T; Kiseleva I; Krutikova E; Donina S; Rekstin A; Larionova N; Mezhenskaya D; Sivak K; Muzhikyan A; Katelnikova A; Rudenko L
    Vaccines (Basel); 2019 Jul; 7(3):. PubMed ID: 31288422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza A Virus Vaccination: Immunity, Protection, and Recent Advances Toward A Universal Vaccine.
    Lopez CE; Legge KL
    Vaccines (Basel); 2020 Aug; 8(3):. PubMed ID: 32756443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles underlying rational design of live attenuated influenza vaccines.
    Jang YH; Seong BL
    Clin Exp Vaccine Res; 2012 Jul; 1(1):35-49. PubMed ID: 23596576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine Cross-Reactive Nonneutralizing Polyclonal IgG1 Antibodies Induced by Influenza Vaccine Inhibit the Cross-Protective Effect of IgG2 against Heterologous Virus in Mice.
    Shibuya M; Aoshi T; Kuroda E; Yoshioka Y
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
    Ghorbani A; Ngunjiri JM; Xia M; Elaish M; Jang H; Mahesh KC; Abundo MC; Jiang X; Lee CW
    Vaccine; 2019 Feb; 37(10):1356-1364. PubMed ID: 30691981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins.
    Jazayeri SD; Poh CL
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31683888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.
    Rajão DS; Pérez DR
    Front Microbiol; 2018; 9():123. PubMed ID: 29467737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine approaches conferring cross-protection against influenza viruses.
    Vemula SV; Sayedahmed EE; Sambhara S; Mittal SK
    Expert Rev Vaccines; 2017 Nov; 16(11):1141-1154. PubMed ID: 28925296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.